Anfield Capital Management, LLC Exelixis, Inc. Transaction History

Anfield Capital Management, LLC

  • $263 Million
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 09, 2022
BUY
$15.68 - $22.27 $1,458 - $2,071
93 Added 2.71%
3,531 $55,000
Q2 2022

Aug 09, 2022
BUY
$17.44 - $23.16 $21,259 - $28,232
1,219 Added 54.93%
3,438 $72,000
Q1 2022

May 13, 2022
BUY
$17.03 - $22.67 $37,789 - $50,304
2,219 New
2,219 $50,000

Others Institutions Holding EXEL

# of Institutions
541
Shares Held
245M
Call Options Held
2.84M
Put Options Held
2.29M
View Full List

About EXELIXIS, INC.

EXEL Quotes by TradingView
  • Ticker EXEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 321,832,000
  • Market Cap $10.8B
  • Description
  • Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...
More about EXEL
Track This Portfolio

Track Anfield Capital Management, LLC Portfolio

Follow Anfield Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Anfield Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Anfield Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email